United States v. Simon, No. 20-1368 (1st Cir. 2021)Annotate this Case
The First Circuit affirmed in full the verdicts of the jury convicting the five defendants in this case on charges brought under the Racketeer Influenced and Corrupt Organizations Act (RICO), 18 U.S.C. 1962(d) but vacated the restitution and forfeiture orders, holding that the jury's special findings and verdicts as to all defendants were affirmed.
Defendants in this case were a group of pharmaceutical executives involved with Insys Therapeutics, Inc., which marketed and sold Subsys, a fentanyl-laced medication approved by the United States Food and Drug Administration for use in the treatment of breakthrough cancer pain. A jury found Defendants guilty of racketeering charges, and the court sentenced Defendants to prison terms of varying lengths. The First Circuit upheld the jury verdicts in full and affirmed the district court's denial of Defendants' various motions for judgments of acquittal and/or new trials but vacated the restitution and forfeiture orders, holding that the district court erred as to these orders.
The court issued a subsequent related opinion or order on August 27, 2021.